• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶9激活与抑制的生化模型

A biochemical model of matrix metalloproteinase 9 activation and inhibition.

作者信息

Vempati Prakash, Karagiannis Emmanouil D, Popel Aleksander S

机构信息

Department of Biomedical Engineering, School of Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

J Biol Chem. 2007 Dec 28;282(52):37585-96. doi: 10.1074/jbc.M611500200. Epub 2007 Sep 11.

DOI:10.1074/jbc.M611500200
PMID:17848556
Abstract

Matrix metalloproteinases (MMPs) are a class of extracellular and membrane-bound proteases involved in an array of physiological processes, including angiogenesis. We present a detailed computational model of MMP9 activation and inhibition. Our model is validated to existing biochemical experimental data. We determine kinetic rate constants for the processes of MMP9 activation by MMP3, MMP10, MMP13, and trypsin; inhibition by the tissue inhibitors of metalloproteinases (TIMPs) 1 and 2; and MMP9 deactivation. This computational approach allows us to investigate discrepancies in our understanding of the interaction of MMP9 with TIMP1. Specifically, we find that inhibition due to a single binding event cannot describe MMP9 inhibition by TIMP1. Temporally accurate biphasic inhibition requires either an additional isomerization step or a second lower affinity isoform of MMP9. We also theoretically characterize the MMP3/TIMP2/pro-MMP9 and MMP3/TIMP1/pro-MMP9 systems. We speculate that these systems differ significantly in their time scales of activation and inhibition such that MMP9 is able to temporarily overshoot its final equilibrium value in the latter. Our numerical simulations suggest that the ability of pro-MMP9 to complex TIMP1 increases this overshoot. In all, our analysis serves as a summary of existing kinetic data for MMP9 and a foundation for future models utilizing MMP9 or other MMPs under physiologically well defined microenvironments.

摘要

基质金属蛋白酶(MMPs)是一类参与包括血管生成在内的一系列生理过程的细胞外和膜结合蛋白酶。我们提出了一个详细的MMP9激活和抑制的计算模型。我们的模型已根据现有的生化实验数据进行了验证。我们确定了MMP3、MMP10、MMP13和胰蛋白酶激活MMP9过程的动力学速率常数;金属蛋白酶组织抑制剂(TIMPs)1和2的抑制作用;以及MMP9失活的动力学速率常数。这种计算方法使我们能够研究我们对MMP9与TIMP1相互作用理解上的差异。具体而言,我们发现单次结合事件导致的抑制无法描述TIMP1对MMP9的抑制作用。时间上精确的双相抑制需要一个额外的异构化步骤或MMP9的第二种低亲和力异构体。我们还从理论上对MMP3/TIMP2/pro-MMP9和MMP3/TIMP1/pro-MMP9系统进行了表征。我们推测这些系统在激活和抑制的时间尺度上有显著差异,以至于在后者中MMP9能够暂时超过其最终平衡值。我们的数值模拟表明,pro-MMP9与TIMP1形成复合物的能力增加了这种超调。总之,我们的分析总结了MMP9现有的动力学数据,并为未来在生理上定义明确的微环境下利用MMP9或其他MMPs的模型奠定了基础。

相似文献

1
A biochemical model of matrix metalloproteinase 9 activation and inhibition.基质金属蛋白酶9激活与抑制的生化模型
J Biol Chem. 2007 Dec 28;282(52):37585-96. doi: 10.1074/jbc.M611500200. Epub 2007 Sep 11.
2
In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.金属蛋白酶MMP1、MMP2、MMP3、MMP9及其抑制剂TIMP1和TIMP2在人肾细胞癌中的原位基因表达及定位
Oncol Rep. 2006 May;15(5):1379-84.
3
Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.MMP2、MMP9、MT1-MMP、TIMP1和TIMP2 mRNA在心脏瓣膜病变中的表达。
J Pathol. 2001 Jun;194(2):225-31. doi: 10.1002/path.850.
4
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.基质金属蛋白酶及其组织抑制剂在人视神经乳头星形胶质细胞中的表达
Glia. 2001 Mar 1;33(3):205-16. doi: 10.1002/1098-1136(200103)33:3<205::aid-glia1019>3.0.co;2-d.
5
Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.胰岛素样生长因子结合蛋白相关蛋白 1 敲低通过调节 MMPs/TIMPs 减轻小鼠肝纤维化。
Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):38-47. doi: 10.1016/j.hbpd.2018.08.008. Epub 2018 Aug 29.
6
Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.联合检测血浆基质金属蛋白酶2(MMP2)、基质金属蛋白酶9(MMP9)和组织金属蛋白酶抑制剂1(TIMP1)可提高膀胱移行细胞癌的无创检测水平。
BMC Urol. 2006 Aug 10;6:19. doi: 10.1186/1471-2490-6-19.
7
Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.腹主动脉瘤患者生物学相关候选基因多态性的遗传分析。
J Vasc Surg. 2005 Jun;41(6):1036-42. doi: 10.1016/j.jvs.2005.02.020.
8
The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue.辛伐他汀对人管腔内血栓和腹主动脉瘤组织中 NGAL、基质金属蛋白酶及其组织抑制剂的影响。
Eur J Vasc Endovasc Surg. 2015 May;49(5):549-55. doi: 10.1016/j.ejvs.2015.02.011. Epub 2015 Mar 21.
9
Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.大鼠胰腺星状细胞分泌基质金属蛋白酶:对细胞外基质周转的影响。
Gut. 2003 Feb;52(2):275-82. doi: 10.1136/gut.52.2.275.
10
Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.头颈部癌中基质金属蛋白酶MMP1、MMP2、MMP9及其组织抑制剂TIMP1、TIMP2、TIMP3的免疫组织化学研究
Otolaryngol Pol. 2016 Jun 30;70(3):32-43. doi: 10.5604/00306657.1202546.

引用本文的文献

1
Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes.高血压疾病中的金属蛋白酶(MMPs):作用、功能、药理学及减轻病理生理变化的潜在策略
Front Pharmacol. 2025 May 26;16:1559288. doi: 10.3389/fphar.2025.1559288. eCollection 2025.
2
Sensitivity Analysis to Isolate the Effects of Proteases and Protease Inhibitors on Extracellular Matrix Turnover.敏感性分析以分离蛋白酶和蛋白酶抑制剂对细胞外基质周转的影响。
bioRxiv. 2025 Feb 27:2025.02.21.639501. doi: 10.1101/2025.02.21.639501.
3
A mathematical model of glomerular fibrosis in diabetic kidney disease to predict therapeutic efficacy.
一种用于预测糖尿病肾病中肾小球纤维化治疗效果的数学模型。
Front Pharmacol. 2024 Oct 25;15:1481768. doi: 10.3389/fphar.2024.1481768. eCollection 2024.
4
Redefining metalloproteases specificity through network proteolysis.通过网络蛋白水解重新定义金属蛋白酶的特异性。
Trends Mol Med. 2024 Feb;30(2):147-163. doi: 10.1016/j.molmed.2023.11.001. Epub 2023 Nov 29.
5
Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody.使用新型抗MMP9抗体对慢性炎症性疾病中的活性MMP9进行表征。
Antibodies (Basel). 2023 Jan 18;12(1):9. doi: 10.3390/antib12010009.
6
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients.SOMAscan 蛋白质组学在肌萎缩侧索硬化症患者中鉴定出新型血浆蛋白。
Int J Mol Sci. 2023 Jan 18;24(3):1899. doi: 10.3390/ijms24031899.
7
Tumor necrosis factor-α and matrix metalloproteinase-9 cooperatively exacerbate neurovascular degeneration in the neonatal rat retina.肿瘤坏死因子-α和基质金属蛋白酶-9协同加剧新生大鼠视网膜的神经血管退变。
Cell Tissue Res. 2022 Nov;390(2):173-187. doi: 10.1007/s00441-022-03670-5. Epub 2022 Jul 27.
8
Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro.环氧化酶抑制作用改变人胶质母细胞瘤细胞体外的增殖、迁移和侵袭特性。
Int J Mol Sci. 2021 Apr 21;22(9):4297. doi: 10.3390/ijms22094297.
9
A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome.小鼠中Col4a3胶原结构域的甘氨酸替代重现了迟发性奥尔波特综合征。
Matrix Biol Plus. 2020 Dec 30;9:100053. doi: 10.1016/j.mbplus.2020.100053. eCollection 2021 Feb.
10
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling.原花青素通过降低 GM-CSF/TSLP/STAT3/β-连环蛋白信号通路抑制乳腺癌进展。
Int J Mol Sci. 2020 Sep 2;21(17):6357. doi: 10.3390/ijms21176357.